Autoimmune Encephalitis: Distinguishing Features and Specific Therapies

Area of Science:

• Neuroimmunology
• Neurology
• Autoimmune Diseases

Background:

• Autoimmune encephalitis presents with subacute altered mental status, progressing to autonomic instability and refractory seizures.
• Antibodies targeting synaptic surface proteins disrupt neuronal function, leading to severe neurological deficits.
• Diagnostic challenges arise from minimal detectable inflammatory brain damage, unlike other autoimmune central nervous system diseases.

Purpose of the Study:

• To review the pathogenesis, diagnosis, and current and emerging therapies for autoimmune encephalitis.
• To emphasize the importance of early multidisciplinary team engagement for optimal patient outcomes.
• To highlight the evolving landscape of managing this critical neurological condition.

Main Methods:

• Literature review of pathogenesis, diagnosis, and treatment strategies for autoimmune encephalitis.
• Analysis of diagnostic challenges and the role of autoantibodies.
• Evaluation of current and novel therapeutic approaches.

Main Results:

• Autoimmune encephalitis is antibody-mediated, targeting synaptic proteins and causing functional alterations.
• Subtle or absent inflammatory brain damage complicates diagnosis.
• Effective management requires prompt diagnosis and multidisciplinary intervention.

Conclusions:

• Early diagnosis and intervention are critical for improving outcomes in autoimmune encephalitis.
• The understanding and treatment of autoimmune encephalitis are continually advancing.
• Multidisciplinary collaboration is essential for comprehensive patient care.